Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI)
Ramesh Nadarajah1,2,3, Peter Ludman4, Yolande Appelman5
1Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, LS2 9JT Leeds, UK.
European Heart Journal. Quality of Care & Clinical Outcomes
|October 19, 2022
Summary
This study examined Non-ST-segment elevation myocardial infarction (NSTEMI) care and outcomes globally. It assessed adherence to 2015 European Society of Cardiology (ESC) guidelines, identifying potential barriers to optimal NSTEMI management.
Area of Science:
- Cardiology
- Clinical Research
- Public Health
Background:
- Non-ST-segment elevation myocardial infarction (NSTEMI) is a common acute coronary syndrome with significant morbidity and mortality.
- Optimal management of NSTEMI is crucial for improving patient outcomes and adherence to established guidelines.
Purpose of the Study:
- To assess international patterns in NSTEMI management and outcomes.
- To evaluate compliance with the 2015 European Society of Cardiology (ESC) Guidelines for NSTEMI.
- To identify potential barriers to optimal NSTEMI care.
Main Methods:
- Prospective, international, observational registry (EORP NSTEMI Registry).
- Inclusion of 3620 consecutive adult NSTEMI patients from 287 centers in 59 countries.
- Data collection on baseline characteristics, in-hospital outcomes, 30-day mortality, and guideline-recommended interventions.
Main Results:
- Data collected on 3620 NSTEMI patients across 59 countries.
- Registry captured baseline characteristics, major outcomes (death, heart failure, shock, bleeding, stroke), and 30-day mortality.
- Detailed information on guideline-recommended care interventions was recorded.
Conclusions:
- The EORP NSTEMI Registry offers unique insights into contemporary NSTEMI patient management.
- Findings will illuminate compliance with 2015 ESC NSTEMI Guidelines.
- The study aims to uncover barriers to optimal NSTEMI management.
More Related Videos
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
20.3K
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.4K
Related Concept Videos
01:30Acute Coronary Syndrome III: Diagnostic Studies
20
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
01:30Acute Coronary Syndrome I: Introduction
56
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56
01:17Imaging Studies for Cardiovascular System I:Echocardiography
465
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
465
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
32
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
32
01:28Acute Coronary Syndrome IV: Interprofessional Care
22
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
01:11Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K